Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0089 | 0.2307 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0196 | 1 |
Brugia malayi | mbt repeat family protein | 0.0046 | 0.0847 | 0.1003 |
Brugia malayi | Probable ClpP-like protease | 0.0089 | 0.2307 | 0.2734 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0187 | 0.5632 | 0.5632 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0058 | 0.1261 | 0.1261 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0058 | 0.1261 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0196 | 0.0848 |
Schistosoma mansoni | hypothetical protein | 0.0193 | 0.5852 | 0.5852 |
Brugia malayi | glutaminase DH11.1 | 0.0269 | 0.844 | 1 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0056 | 0.1177 | 0.1177 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0196 | 0.0232 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0196 | 0.0232 |
Echinococcus granulosus | geminin | 0.0193 | 0.5852 | 0.5852 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.2307 | 0.2734 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0847 | 0.1003 |
Brugia malayi | mbt repeat family protein | 0.0046 | 0.0847 | 0.1003 |
Echinococcus multilocularis | geminin | 0.0193 | 0.5852 | 0.5852 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 1 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0089 | 0.2307 | 0.2307 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0089 | 0.2307 | 1 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0046 | 0.0847 | 0.0847 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.2734 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0196 | 1 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0056 | 0.1177 | 0.1177 |
Schistosoma mansoni | hypothetical protein | 0.0315 | 1 | 1 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0056 | 0.1177 | 0.1177 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0196 | 0.0848 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0031 | 0.0316 | 0.137 |
Onchocerca volvulus | 0.0056 | 0.1177 | 1 | |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.2307 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0193 | 0.5852 | 0.5852 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.2734 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0031 | 0.0316 | 0.137 |
Loa Loa (eye worm) | glutaminase 2 | 0.0269 | 0.844 | 1 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.5 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0031 | 0.0316 | 0.137 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0046 | 0.0847 | 0.0847 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0196 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0058 | 0.1261 | 0.4744 |
Mycobacterium ulcerans | glutaminase | 0.0269 | 0.844 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0196 | 0.0848 |
Echinococcus multilocularis | tumor suppressor p53 binding protein 1 | 0.0315 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0196 | 1 |
Schistosoma mansoni | glutaminase | 0.0269 | 0.844 | 0.844 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0089 | 0.2307 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.5 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0187 | 0.5632 | 0.5632 |
Schistosoma mansoni | hypothetical protein | 0.0233 | 0.721 | 0.721 |
Toxoplasma gondii | hypothetical protein | 0.0031 | 0.0316 | 0.137 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0056 | 0.1177 | 0.1177 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0046 | 0.0847 | 0.1003 |
Trichomonas vaginalis | glutaminase, putative | 0.0269 | 0.844 | 1 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0058 | 0.1261 | 0.1261 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0046 | 0.0847 | 0.0847 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0089 | 0.2307 | 0.2307 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0058 | 0.1261 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0269 | 0.844 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0089 | 0.2307 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0196 | 0.0848 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 46.0617 uM | PUBCHEM_BIOASSAY: Confirmation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK): for Probe SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1721, AID2266] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.